期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Immediate oral amiodarone re-challenge following the development of parenteral-induced acute liver toxicity 被引量:2
1
作者 Joseph Off enbacher Farnam Kazi +4 位作者 Niel Chen Mohamed Mohamed Jasmine Chacko Nils Guttenplan vincent nguyen 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2021年第4期321-323,共3页
Dear editor,Amiodarone is a class Ⅲ antiarrhythmic medication commonly used in the emergency department (ED) and other critical care settings to treat several types of arrhythmias while also serving as a fixture of t... Dear editor,Amiodarone is a class Ⅲ antiarrhythmic medication commonly used in the emergency department (ED) and other critical care settings to treat several types of arrhythmias while also serving as a fixture of the Advanced Cardiac Life Support algorithm.[1] Its mechanism of action primarily involves blocking potassium channel currents during myocyte repolarization with additional effects on betaadrenergic receptors and both sodium and calcium channel blockade.[2] One of amiodarone’s less known complications is the development of acute hepatotoxicity with intravenous(IV) administration.[3] While discontinuation has been recommended, there is limited literature to help guide management when clinical factors warrant its continuation. 展开更多
关键词 CONTINUATION editor POTASSIUM
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部